LCFT NON-MEDICAL PRESCRIBERS — All Prescriptions & Medications
Practice Code: Y04023 | PRESTON, PR5 6AW
Over the last 12 months, LCFT NON-MEDICAL PRESCRIBERS prescribed 3,251 items across 78 different medications at a total cost of £131,527 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Prednisolone | 312 | 16.4K | £569 | -61.0% ▼ |
| Doxycycline hyclate | 177 | 1,407 | £151 | -65.5% ▼ |
| Amoxicillin | 123 | 3,935 | £158 | -86.8% ▼ |
| Sacubitril/valsartan | 120 | 6,692 | £10.9K | -49.9% ▼ |
| Bisoprolol fumarate | 114 | 3,444 | £77 | -97.2% ▼ |
| 88 | 1,662 | £14.7K | +216.3% ▲ | |
| 87 | 1,422 | £5.6K | +311.5% ▲ | |
| 86 | 156 | £2.8K | +1,164.1% ▲ | |
| Ramipril | 72 | 2,044 | £80 | -98.5% ▼ |
| 70 | 125 | £605 | +72.0% ▲ | |
| Spironolactone | 64 | 1,778 | £177 | -88.1% ▼ |
| Dapagliflozin | 63 | 1,764 | £2.2K | -95.0% ▼ |
| 61 | 107 | £2.1K | +598.5% ▲ | |
| 56 | 8,085 | £963 | -74.1% ▼ | |
| Furosemide | 47 | 1,778 | £34 | -96.8% ▼ |
| 45 | 980 | £4.5K | +229.9% ▲ | |
| Insulin glargine | 44 | 209 | £1.9K | -84.5% ▼ |
| 43 | 9,675 | £5.8K | +15.8% ▲ | |
| 40 | 48 | £270 | -83.1% ▼ | |
| 39 | 3,704 | £196 | -85.9% ▼ | |
| Erdosteine | 35 | 700 | £167 | +264.7% ▲ |
| Salbutamol | 33 | 933 | £685 | -98.7% ▼ |
| 33 | 126 | £1.2K | +159.4% ▲ | |
| Insulin Lispro | 30 | 151 | £1.1K | -60.8% ▼ |
| 30 | 615 | £1.3K | -31.8% ▼ | |
| 30 | 98 | £12.9K | +377.7% ▲ | |
| Flucloxacillin sodium | 29 | 2,504 | £163 | -93.6% ▼ |
| 28 | 132 | £51 | -87.3% ▼ | |
| Insulin aspart | 27 | 120 | £622 | -92.9% ▼ |
| 26 | 355 | £2.2K | +26.7% ▲ | |
| 25 | 490 | £1.4K | +59.3% ▲ | |
| 25 | 63 | £10.1K | -30.0% ▼ | |
| Metformin hydrochloride | 24 | 1,429 | £39 | -99.3% ▼ |
| Tirzepatide | 24 | 24 | £2.1K | -87.6% ▼ |
| 23 | 482 | £1.5K | -9.5% ▼ | |
| 22 | 12.6K | £224 | -97.8% ▼ | |
| 21 | 30 | £705 | -69.3% ▼ | |
| Other emollient preparations | 20 | 12.5K | £157 | -96.7% ▼ |
| Empagliflozin | 19 | 532 | £661 | -97.0% ▼ |
| 18 | 520 | £639 | -54.3% ▼ | |
| 18 | 344 | £1.1K | +8.2% ▲ | |
| 18 | 63 | £348 | -42.0% ▼ | |
| 18 | 46 | £616 | +152.8% ▲ | |
| 18 | 640 | £210 | -76.7% ▼ | |
| Eplerenone | 17 | 392 | £56 | -93.6% ▼ |
| Nebivolol | 17 | 588 | £716 | -84.0% ▼ |
| 17 | 2,500 | £464 | -96.4% ▼ | |
| 17 | 37 | £3.5K | +231.4% ▲ | |
| Digoxin | 16 | 448 | £32 | -95.8% ▼ |
| Candesartan cilexetil | 16 | 476 | £32 | -98.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.